Zoar Ltd. files Form F-4 registration statement, including preliminary proxy, for proposed merger with Impact BioMedical

Zoar Ltd. (formerly Dr. Ashley's Limited) filed a Form F-4 registration statement with the SEC, including a preliminary proxy, for its proposed business combination with Impact BioMedical, Inc. (DSS subsidiary), according to a press release. The filing is a step toward completing the transaction.

Detected & updated continuously · Source: Nebula